BIOX vs. FULC

In the year-to-date period, BIOX achieves a -53.90% return, which is significantly lower than FULC's -28.30% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Bioceres Crop Solutions Corp. (BIOX) and Fulcrum Therapeutics, Inc. (FULC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current BIOX Sharpe Ratio is -1.50, which is lower than the FULC Sharpe Ratio of -0.29. The chart below compares the historical Sharpe Ratios of BIOX and FULC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither BIOX nor FULC has paid dividends to shareholders.

The maximum BIOX drawdown since its inception was -62.00%, smaller than the maximum FULC drawdown of -92.70%. Use the drawdown chart below to compare losses from any high point for BIOX and FULC. For additional features, visit the drawdowns tool.

The current volatility for Bioceres Crop Solutions Corp. (BIOX) is 13.89%, while Fulcrum Therapeutics, Inc. (FULC) has a volatility of 26.18%. This indicates that BIOX experiences smaller price fluctuations and is considered to be less risky than FULC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Bioceres Crop Solutions Corp. and Fulcrum Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.